Clinical-stage company developing gene therapies for severe genetic and rare diseases.
Issues related to the Patient Affordability, Value and Efficacy Act (PAVE); issues related to H.R. 2296, the METRIC Act. Monitored issues related to drug pricing; S. 2543, Prescription Drug Pricing Reduction Act of 2019 and issues related to value-based payment; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
HCR - Health Issues MMM - Medicare/Medicaid
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
STACEY HUGHES EMILY PORTER EMILY PORTER STACEY HUGHES